Top Markets
Coin of the day
Alliance Pharma plc Alliance Pharma plc

Alliance Pharma plc

APH
Rank in Stocks #13762
Alliance Pharma plc is a pharmaceutical firm with an expansive global reach,... Alliance Pharma plc is a pharmaceutical firm with an expansive global reach, conducting business across Europe, the Middle East, Africa, the Asia Pacific region, China, and the Americas. The company's core activities involve sourcing, promoting, and distributing a diverse array of consumer healthcare items and prescribed medications. It currently manages the marketing rights for approximately 80 different products within these categories. Additionally, its offerings extend to medical devices, dietary supplements, and cosmetic goods. Notable brands within its portfolio include Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen. Founded in 1996, Alliance Pharma plc maintains its corporate base in Chippenham, United Kingdom.
Share Price
$0.85814713
Last synced: 2025-05-14
Market Cap
$463.40M
Change (1 day)
-2.52%
Change (1 year)
0.00%
Country
GB
Trade Alliance Pharma plc (APH)

Category

Number of shares outstanding for Alliance Pharma plc (APH)
Number of shares outstanding as of December 2024: 540.57M
According to Alliance Pharma plc latest financial reports and stock price the company's current number of shares outstanding is 540.57M. At the end of December 2023 the company had 540.15M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Alliance Pharma plc (APH) from 2001 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 540.57M 0.02%
2024 540.48M 0.06%
2023 540.15M 0.12%
2022 539.48M 0.78%
2021 535.30M 2.61%
2020 521.69M 0.19%
2019 520.69M 4.72%
2018 497.20M 4.93%
2017 473.84M 0.94%
2016 469.42M 72.12%
2015 272.73M 3.25%
2014 264.15M -0.33%
2013 265.01M 0.78%
2012 262.97M 0.06%
2011 262.82M 16.23%
2010 226.12M 6.70%
2009 211.91M 7.15%
2008 197.78M 22.04%
2007 162.06M 3.45%
2006 156.66M 6.32%
2005 147.36M 84.26%
2004 79.97M 47.97%
2002 54.05M 92.21%
2001 28.12M 0.00%
Shares Outstanding for similar companies or competitors